Working... Menu

Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors (BCLS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03257670
Recruitment Status : Recruiting
First Posted : August 22, 2017
Last Update Posted : March 27, 2018
Syneron Candela
Information provided by (Responsible Party):
James Whiteside, University of Cincinnati

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 1, 2018
  Estimated Study Completion Date : November 1, 2018